companydata.dkOBA-PHARMA ApS: Financial statements 2016
CVR: 19995607
OBA-PHARMA ApS (CVR 19995607) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 2,809,440 and a net result of DKK 2,206,997 compared with DKK 2,490,654 the year before. That is a decrease of 12.9% compared with the year before. Equity amounted to DKK 2,796,055. The solvency ratio was 51.2%.
- Gross Profit
- 2,809,440 kr.
- Profit/Loss
- 2,206,997 kr.
- Equity
- 2,796,055 kr.
- Total Assets
- 5,459,639 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 2.8 mio. | 2.2 mio. | 2.8 mio. | - |
| 2015 | - | 3.2 mio. | 2.5 mio. | 3.1 mio. | - |
| 2014 | - | 3.7 mio. | 3.1 mio. | 3.6 mio. | - |
| 2013 | - | 2.9 mio. | 2.4 mio. | 3 mio. | - |
| 2012 | - | 3 mio. | 2.2 mio. | 7.6 mio. | - |
How creditworthy is OBA-PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
OBA-PHARMA ApS has published its annual report for 2015. Gross profit came to DKK 3,225,695, and the net result was DKK 2,490,654.
About OBA-PHARMA ApS
OBA-PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PBH 25.376 ApS. The management consists of Malene Dybdahl Birch. The company is owned by LEV-VEL ApS and NLDB Holding ApS. The company has 0 employees. In 2024, the company reported a gross profit of DKK 3,402,201 and a net result of DKK 2,670,973 compared with DKK 2,073,440 the year before. Equity amounted to DKK 674,251.